Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

UNITED THERAPEUTICS (UTHR) Other Gross PP&E Adjustments: 2009-2025

Historic Other Gross PP&E Adjustments for UNITED THERAPEUTICS (UTHR) over the last 5 years, with Sep 2025 value amounting to $2.1 billion.

  • UNITED THERAPEUTICS's Other Gross PP&E Adjustments rose 28.91% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 21.79%. This contributed to the annual value of $1.7 billion for FY2024, which is 16.29% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Other Gross PP&E Adjustments of $2.1 billion as of Q3 2025, which was up 11.12% from $1.9 billion recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Other Gross PP&E Adjustments high stood at $2.1 billion for Q3 2025, and its period low was $1.0 billion during Q1 2021.
  • Its 3-year average for Other Gross PP&E Adjustments is $1.6 billion, with a median of $1.6 billion in 2024.
  • Data for UNITED THERAPEUTICS's Other Gross PP&E Adjustments shows a peak YoY climbed of 28.91% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Other Gross PP&E Adjustments stood at $1.1 billion in 2021, then grew by 10.76% to $1.2 billion in 2022, then grew by 18.44% to $1.5 billion in 2023, then climbed by 16.29% to $1.7 billion in 2024, then climbed by 28.91% to $2.1 billion in 2025.
  • Its Other Gross PP&E Adjustments was $2.1 billion in Q3 2025, compared to $1.9 billion in Q2 2025 and $1.8 billion in Q1 2025.